Dale Broadrick, 10% Owner at BioRestorative Therapies, Inc. (BRTX), bought 300 shares at $2.83 ($849) on 2022-09-23, disclosed to the SEC on 2022-09-27.
Open-market purchase of $849 BRTX by 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Negative factors outweigh the positive ones.
| Filing → |
| BRTX | BUY | 2024-02-09 | $325K | — | Filing → |
| BRTX | SELL | 2023-12-05 | $470 | — | Filing → |
| BRTX | SELL | 2023-12-01 | $525 | — | Filing → |